Clinical Trials Logo

Hyperglycemia clinical trials

View clinical trials related to Hyperglycemia.

Filter by:

NCT ID: NCT04636489 Active, not recruiting - Hyperglycemia Clinical Trials

Effect of Prebiotics on Blood Glucose Management

Start date: November 30, 2020
Phase: N/A
Study type: Interventional

This survey is designed to investigate the effect of highland barley β-glucan supplementation on the regulatory of blood glucose, gut microbiota and cardiovascular risk fators in subjects with hyperglycemia.

NCT ID: NCT04473378 Active, not recruiting - Breast Cancer Clinical Trials

Glucose Monitoring During Chemotherapy

Start date: October 31, 2019
Phase:
Study type: Observational

This is a research study to look at blood sugar changes during chemotherapy using a continuous blood sugar monitoring device. The device uses patches that attach to the skin on the back of the arm to measure blood sugar changes for the duration of the chemotherapy course. Each patch lasts for about 2-weeks. During chemotherapy visits, new patches will be placed and will be worn until the chemotherapy course is complete. Participants will be in this study for 6 months. Approximately 50 patients will be enrolled in this study.

NCT ID: NCT04341571 Active, not recruiting - PreDiabetes Clinical Trials

Effect of Probiotics Versus Metformin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Prediabetes.

Start date: October 24, 2019
Phase: Phase 2
Study type: Interventional

Pre diabetes (PD) is a term that refers to alterations in blood glucose levels, including impaired fasting glucose (IFG), impaired glucose tolerance (IGT) or both, and increase in glycated hemoglobin (HbA1c), all this factors involving a higher risk to develop type 2 diabetes mellitus (T2DM). The efficacy of pharmacotherapy in the prevention of diabetes in adults with pre diabetes has been demonstrated, the first line of pharmacology treatment is metformin, on the other hand, probiotics administration has been reported to be one of the most widely used approaches to modulate the gut microbiota and subsequently prevent or delay the incidence of T2DM. Probiotics are live microorganisms which when administered in adequate amounts confer a health benefit on the host. Has been demonstrated the hypoglycemic effects of the probiotics in different clinical trials in type 2 diabetes mellitus and pre diabetes, but no yet compared with metformin, for this reason comparing it´s activity against metformin in pre diabetes would provide impact information on a new alternative treatment compared with the standard pharmacological treatment. The aim of the study is evaluate the effect of administration of probiotic versus metformin on glycemic control, insulin secretion and insulin sensitivity in patients with pre diabetes.

NCT ID: NCT04333823 Active, not recruiting - Clinical trials for Diabetes Mellitus, Type 1

Adolescent Type 1 Diabetes Treatment With SGLT2i for hyperglycEMia & hyPerfilTration Trial

ATTEMPT
Start date: December 11, 2020
Phase: Phase 3
Study type: Interventional

The ATTEMPT (Adolescent Type 1 diabetes Treatment with SGLT2i for hyperglycEMia & hyPerfilTration Trial) is a multi-center, double-blinded, randomized, placebo-controlled trial to evaluate the effect of treatment with Dapagliflozin when compared to placebo, in combination with adjustable insulin, on measured GFR in adolescents with T1D 12 to <19 years of age over a 16-week treatment period.

NCT ID: NCT04060056 Active, not recruiting - Clinical trials for Diabetes, Gestational

Westlake Precision Birth Cohort

WeBirth
Start date: August 30, 2019
Phase: N/A
Study type: Interventional

The Westlake Precision Birth Cohort (WeBirth) is a prospective cohort study among women with hyperglycemia during pregnancy and their offspring living in Hangzhou, China. The primary aim of this cohort is to characterize the continuous blood glucose response to dietary intake and physical activity among pregnant women with gestational diabetes mellitus (GDM) over 2 weeks, and to facilitate the development of personalized nutritional/lifestyle recommendation among these patients. Another aim of WeBirth is to investigate the association of dietary intake and physical activity together with continuous glucose change during pregnancy on the adverse birth outcomes including preterm birth, macrosomia and large-for-gestational-age birth. The secondary aim is to investigate the prospective associations of diet, physical activity and continuous glucose change over 2 weeks among the participants with long-term metabolic health of these women and their offspring.

NCT ID: NCT03978702 Active, not recruiting - Pancreas Cancer Clinical Trials

Evaluation of the Impact of Pancreatectomy on Systemic Immunity

IMMUNOPANC
Start date: February 24, 2021
Phase: N/A
Study type: Interventional

The study aims at establishing the profile of the immune reaction that occurs in the early surgical suites after pancreatectomy. Blood samples will be collected before surgery, (Day-1), at day0, and after surgery at Day 1, Day 3, Day 7 at 1 year after pancreatectomy. Mass cytometry, genomic and transcriptomic approaches will be used to evaluate the immune systemic modulation after surgery.

NCT ID: NCT03731637 Active, not recruiting - Diabetes Clinical Trials

A Study to Establish a New Onset Hyperglycemia and Diabetes Cohort

NOD
Start date: October 15, 2018
Phase:
Study type: Observational

Create a large biobank of blood samples and data from subjects with new onset hyperglycemia and diabetes (NOD).

NCT ID: NCT03665207 Active, not recruiting - Critical Illness Clinical Trials

Tight Versus Liberal Blood Glucose Control in Adult Critically Ill Patients

TGC-fast
Start date: September 18, 2018
Phase: Phase 3
Study type: Interventional

Critically ill patients usually develop hyperglycemia, which is associated with an increased risk of morbidity and mortality. Controversy exists on whether targeting normal blood glucose concentrations with insulin therapy, referred to as tight blood glucose control (TGC) improves outcome of these patients, as compared to tolerating hyperglycemia. It remains unknown whether TGC, when applied with optimal tools to avoid hypoglycemia, is beneficial in a context of withholding early parenteral nutrition. The TGC-fast study hypothesizes that TGC is beneficial in adult critically ill patients not receiving early parenteral nutrition, as compared to tolerating hyperglycemia.

NCT ID: NCT03577964 Active, not recruiting - Clinical trials for Glucose Metabolism Disorders

Development of Pneumonia Due to Alveolar Glucose Levels in Systemic Hyperglycemia

Start date: September 1, 2017
Phase:
Study type: Observational

Incidence of Pneumonia in Patients with high systemic glucose levels.

NCT ID: NCT03576924 Active, not recruiting - Clinical trials for Elevated Blood Sugar

Power of Choice on Autonomy, Motivation, Exercise Adherence, and Cardiorespiratory Fitness

Start date: October 1, 2021
Phase: N/A
Study type: Interventional

People with elevated blood sugar levels are at increased risk of developing chronic medical conditions such as obesity, type 2 diabetes, and cardiovascular disease. Improving cardiorespiratory fitness (CRF) in adults with elevated blood sugar levels is important for preventing the onset of such medical conditions. The primary aim of this study is to determine whether providing a choice between two different types of exercise in a diabetes prevention intervention improves perceived autonomy, exercise motivation, physical activity behavior, and subsequently CRF to a greater extent than imposed exercise among adults with elevated blood sugar.